Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Leukemia. 2013 Oct;27(10):2102-5. doi: 10.1038/leu.2013.110. Epub 2013 Apr 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD20 / metabolism*
  • Blood Cell Count
  • Follow-Up Studies
  • Humans
  • Lymphoproliferative Disorders / blood*
  • Lymphoproliferative Disorders / diagnosis*
  • Lymphoproliferative Disorders / etiology
  • Lymphoproliferative Disorders / mortality
  • Organ Transplantation / adverse effects*
  • Postoperative Complications*
  • Prognosis
  • Prospective Studies
  • Retrospective Studies
  • Survival Rate

Substances

  • Antigens, CD20